SCHEMBL27632573

SCHEMBL27632573

CN(C)c1nc(NC2CCC(N(CCc3ccccc3)C(N)=O)CC2)nc2c1CCCC2

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.39
MCHR1 Q99705 12/20 0.38
ADRA2A P08913 11/20 0.38
SMYD3 Q9H7B4 3/20 0.37
HTR1A P08908 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
HTR2B P41595 1/20 0.37
NPY5R Q15761 1/20 0.37
BCHE P06276 3/20 0.37
ACHE P22303 3/20 0.37
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27632572 1.00 DRD2 (0.39) DRD2MCHR1ADRA2ASMYD3HTR1A
SCHEMBL27652829 0.86 ALDH1A1 (0.35) MCHR1ADRA2AADRA1AHRH1HTR2B
SCHEMBL27652827 0.86 ALDH1A1 (0.35) MCHR1ADRA2AADRA1AHRH1HTR2B
SCHEMBL27632587 0.84 MCHR1 (0.37) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27632588 0.84 MCHR1 (0.37) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27653038 0.84 MCHR1 (0.38) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27653039 0.84 MCHR1 (0.38) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27652712 0.84 MCHR1 (0.43) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27652714 0.84 MCHR1 (0.43) MCHR1ADRA2AHTR1AADRA1AHRH1
SCHEMBL27631302 0.83 MCHR1 (0.44) MCHR1ADRA2AHTR1AADRA1AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100451004-C Pyrimidine derivatives ARENA PHARM INC (JP) 2009-01-14 CN disclosed
CN-1798736-A Novel quinoline, tetrahydroquinazoline and pyrimidine derivatives and methods of treatment related to their use ARENA PHARM INC (JP) 2006-07-05 CN disclosed